Patients with leukemia and those undergoing blood or marrow stem cell transplantation, who themselves have no antibodies to CMV, should receive blood components that are negative for CMV antibodies.

• 白血病患者和进行外周血或骨髓造血干细胞移植的患者如自身没有巨细胞病毒抗体，则应输注巨细胞病毒抗体阴性的血液成分。